CLIMACTERIC SYNDROME TREATMENT METHOD
FIELD: gynecology. ^ SUBSTANCE: synthoxic program activity adaptation factor (SPAAF) is derived from following equation: SPAAF = (Cst%+Aat-III%+Agoap%+ Cts%)/(Cad%+Ca2mg%+Cmda%+Cth%), where Cst signifies blood concentration of serotonin, Aat-III antithrombin III activity, Agoap general oxidation act...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: gynecology. ^ SUBSTANCE: synthoxic program activity adaptation factor (SPAAF) is derived from following equation: SPAAF = (Cst%+Aat-III%+Agoap%+ Cts%)/(Cad%+Ca2mg%+Cmda%+Cth%), where Cst signifies blood concentration of serotonin, Aat-III antithrombin III activity, Agoap general oxidation activity of plasma, Cts T-suppressor concentration, Cad blood concentration of adrenaline, Ca2mga2-macroglobulin concentration, Cmd malonic dialdehyde concentration, and Cth T-helper concentration. Above concentrations and activity are expressed in % based on reference values found in sound males and females 45 to 55 years of age. When SPAAF equals 0.7, pyroxane in dose 0.015 g twice a day over a 7 days period and 0.005-0.01% phytoecdisterone in 40% alcohol in dose 30 drops thrice a day before meal over 2 weeks period are simultaneously administered. When SPAAF equals 0.5, the same treatment is prescribed but pyroxane is administered for 2 weeks and on the 15th day after the last administration the course is repeated. ^ EFFECT: stabilized arterial pressure, normalized metabolism, and improved cerebral blood circulation. ^ 2 ex |
---|